Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01825096 · ClinicalTrials.gov registry record
Simultaneous FMRI and NIRS to Estimate Brain Cerebral Metabolism
A clinical trial, sponsored by Mclean Hospital.
- Completed
- Registry status
- 1
- Enrollment target
NCT01825096: Completed study, sponsored by Mclean Hospital.
NCT01825096 is a clinical trial that has completed, run by Mclean Hospital. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01825096 has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The principal advantages of functional magnetic resonance imaging (fMRI) with blood-oxygenation- level-dependent (BOLD) contrast for studying brain function are: non-invasiveness, ubiquitous availability, relatively high spatiotemporal resolution, and the ability to map function over the entire brain. Thus, BOLD fMRI is the most widely applied technology to study healthy brain function and pathophysiology associated with disease. In studies of drug abuse and psychiatric illness though, normal assumptions mapping BOLD signals to neurometabolism may be violated. Generally, these effects are ignored, resulting in large study-to-study variability. Quantitative fMRI (qfMRI) measures metabolism directly and is more suitable for studies of drug abuse and psychiatric illness. However, qfMRI is too complex for routine use. Cerebral metabolism during brain activation during visual stimulation measured with a new fMRI approach that is simple enough for clinical applications will be compared to CMRO2 activation measured using standard qfMRI.
Primary Outcome
CMRO2 brain activation in visual cortex associated with visual stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-12 |
What the finished NCT01825096 record still lists
NCT01825096 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01825096 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01825096 about?
NCT01825096 is a clinical study titled "Simultaneous FMRI and NIRS to Estimate Brain Cerebral Metabolism". The principal advantages of functional magnetic resonance imaging (fMRI) with blood-oxygenation- level-dependent (BOLD) contrast for studying brain function are: non-invasiveness, ubiquitous availability, relatively high spatiotemporal resolution, and the ability to map function over the entire brai...
What is the current status of trial NCT01825096?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2012-03. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT01825096?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia